On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayJul 02, 2021 11:13 am

NetworkNewsBreaks – Hero Technologies Inc.’s (HENC) Portfolio Leverages Premium Cultivation and Retail Assets

Hero Technologies (OTC: HENC) appears to be ideally positioned in the growing U.S. and Michigan recreational and medical marijuana markets. In Michigan, the state’s sales hit a record $115.4 million in March, a more than twofold increase over March 2020. Meanwhile, the U.S. markets are on a trajectory to reach up to $45.9 billion in annual sales by 2025, or as much as twice the level of sales projected this year. “We are growers and cultivators, developers, builders, engineers, marketers, managers all here to serve Hero Technologies Inc. as we rapidly develop the largest vertically integrated cannabis company the world…

Continue Reading

FridayJul 02, 2021 10:40 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Bringing Researchers Next-Level Tools for Hard-to-Treat Diseases

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is looking to give oncology drug developers an upper hand, thereby increasing the chances of the drugs’ success from the onset. “Raising the success rate for experimental cancer drugs starts in the laboratory, where leading-edge technology could be instrumental in providing prescient insights that ultimately result in better clinical outcomes,” reads a recent article. TumorGenesis, a subsidiary of POAI, has partnered with Swedish cell culture system company Cellevate AB. “The collaboration will involve using TumorGenesis’ expertise in cancer cell culture growth…

Continue Reading

FridayJul 02, 2021 10:25 am

NetworkNewsBreaks – Brain Scientific Inc.’s (BRSF) Pediatric NeuroCap Is First-of-its-Kind for Pediatric Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is bringing to market new technology that allows EEG testing to be deployed rapidly and accurately in children and adolescents. The Pediatric NeuroCap is intended to solve significant barriers limiting EEG monitoring in pediatric care. “Instead of improvising to make adult-size EEG electrodes fit pediatric patients’ smaller head circumference, Brain Scientific fully adapted its revolutionary NeuroCap to be used in children,” reads a recent article. “The Pediatric NeuroCap comes in two sizes and includes 22 integrated, pre-gelled electrodes compliant with the 10-20 international system. With the…

Continue Reading

ThursdayJul 01, 2021 3:16 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Leverages Expansion Resolve, Telecom Partnerships to Build Platform

FingerMotion (OTCQX: FNGR) recently released its financial results for the fiscal year ended February 28, 2021, posting “its highest revenue and year-over-year revenue growth thus far.” According to a recent article, the company’s revenue grew by 82% from the previous financial year 2020, reaching $16.68 million. FNGR’s SMS and MMS segment posted business revenue of $6.13 million for the 2021 fiscal year, an 84% growth from the year before. Its gross profit increased by 71%. The company’s overall growth for the 2021 financial year reflected $2.11 million in positive shareholders’ equity. The article continues, “The 2021 impressive fiscal performance was…

Continue Reading

ThursdayJul 01, 2021 2:42 pm

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Finalizing Design of Innovative Cancer Visualization Technology

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is finalizing the design of its i/Blue Imaging System(TM), with manufacturing expected to be completed in 2022. The system is an innovative technology designed to significantly improve surgeons’ ability to visualize cancerous cells and enable more accurate bladder cancer resection. It solves challenges associated with using blue and white light cystoscopies, which require surgeons to switch back and forth between images and rely on memory to resect. “The company’s advanced technology will show both images simultaneously side-by-side on one screen, providing surgeons with better visualization to remove the cancer and making procedures more efficient,”…

Continue Reading

ThursdayJul 01, 2021 12:38 pm

NetworkNewsBreaks – Vivos Therapeutics Inc.’s (NASDAQ: VVOS) Strides in Treatment Innovation Highlighted in New Book

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, has been a trailblazer in diagnosing and treating mild-to-moderate obstructive sleep apnea (“OSA”). Years of research have culminated in its main product, the Vivos System, which has been instrumental in treating OSA among adults. In his new book, Pneumopedics and Craniofacial Epigenetics, Vivos Therapeutic’s founder and Chief Medical Officer Dr. G. Dave Singh shares the process behind Vivos System’s innovation and the scientific and biological foundation of the product. “Dr. Singh’s primary goal with this book is to spread…

Continue Reading

ThursdayJul 01, 2021 12:22 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Collaborating to Advance Psychedelic Medicine Program

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is partnering with pharmaceutical research companies that will provide support services for the development of its synthetic TRP-8802 psilocybin product. This is on top of a collaboration with pediatric eating disorders expert Jennifer Miller, M.D. of the University of Florida, who is directing the investigation/clinical trials of the product. Fluence, a psychedelic therapy educational platform, will provide design and training for the psychotherapeutic portion of Tryp’s upcoming clinical trials, while Clinlogix, a global novel pharmaceutical product contract research organization, will provide support services. “Tryp announced on May 25 that global pharmaceutical contract development and…

Continue Reading

ThursdayJul 01, 2021 12:03 pm

NetworkNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Positioned Amid Silver’s Rising Demand/Declining Supply

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) is a silver and base metals producer with precious metal projects located in Mexico, Idaho and Germany. According to a recent article, “The World Silver Survey has forecast a rise in total silver demand in 2021 of 15% to 1.03 billion ounces, with industrial demand set to rebound by 8% year-over-year. However, the rosy demand outlook contrasts against the commodity’s rapidly declining supply profile. In 2020, global mine production registered its fourth consecutive annual decline, with silver output declining by 5.9% to 784.4 million ounces.” The piece further clarifies that the…

Continue Reading

ThursdayJul 01, 2021 11:47 am

NetworkNewsBreaks – Asia Broadband Inc. (AABB) Eyes Promising Assay Results in Leveraging Mine-to-Token Strategy

Asia Broadband (OTC: AABB), a precious metals resource holder and cryptocurrency developer, has been assessing several gold mining projects and has issued letters of intent (“LOIs”) for mines and processing facilities in the Mexico-based states of Jalisco and Nayarit. These efforts are underway in order for AABB to add to its gold holdings under its mine-to-token strategy. The company is moving forward with its intent to acquire new gold reserves and recently announced that one of the mines subject to its LOI has produced high-grade assay results from random samples collected throughout the property when due diligence procedures began. “The…

Continue Reading

WednesdayJun 30, 2021 3:19 pm

NetworkNewsBreaks – BAND Royalty Staking Claim as Music Industry Disruptor

BAND Royalty, an enterprising entertainment fintech company, is an industry pioneer to use NFTs based on music royalties and has created the first-ever music-only NFT marketplace. “Using a new type of art NFT that is also a music NFT DeFi opportunity, the company aims to revolutionize the way fans connect with celebrities and performers own their brands by enabling users to share in royalties whenever their favorite songs are performed,” notes a recent article. BAND has already released the first series of NFTs with a DeFi utility divided into eight different rarity levels. Each level represents a select quality and…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217